ALYSON TAYLOR-SMITH: Open Payments
NPI 1023538378 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,124 in 98 payments from 13 companies in 2025. Trend: 2023 $469 · 2024 $1,388 · 2025 $3,124
Food & beverage: $1,889Travel & lodging: $1,235
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 13 | $1,598 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $282 |
| ABBVIE INC. | 14 | $270 |
| Axsome Therapeutics, Inc. | 11 | $190 |
| Corium, LLC | 10 | $166 |
| Teva Pharmaceuticals USA, Inc. | 10 | $154 |
| Lundbeck LLC | 10 | $150 |
| Otsuka America Pharmaceutical, Inc. | 5 | $110 |
| Vanda Pharmaceuticals Inc. | 3 | $78 |
| Collegium Pharmaceutical, Inc. | 2 | $46 |
Products named: SPRAVATO, CAPLYTA, VRAYLAR, REXULTI, Auvelity, Azstarys, INVEGA SUSTENNA, UZEDY.
Industry payments across KS — which companies pay providers there.
